The study involved 550 healthy U.S. adults ages 18 to 75 who received either the experimental combo vaccine and a placebo or ...

Moderna's new mRNA vaccine targets both flu and COVID-19, showing strong immune responses in trials, while non-celiac gluten ...

The FDA has set a deadline of August to decide on whether to approve the vaccine. Read more at straitstimes.com. Read more at ...

Moderna said the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application.

The messenger RNA COVID-19 vaccine is not tied to neurodevelopmental disorders in youth whose mothers who were vaccinated immediately before or during pregnancy, data show.The study, presented at The ...

Moderna (MNRNA) stock rises as FDA accepts mRNA-1010 flu vaccine BLA, setting Aug. 5, 2026 action date. Read more here.

Hot spots within the ED included the acute-care area (9 of 13 samples positive), the public waiting room (6 of 12), and a walkway area (1 of 1). In the ICU, positive samples were detected in a staff ...

The FDA issued a refuse-to-file letter for Moderna’s mRNA-based flu vaccine amid a shift toward stricter scrutiny of mRNA ...

ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...

In the early 1960s, after studies confirmed that it was linked to congenital disorders in more than 10,000 children, ...